featured
Real-World Effectiveness of Adalimumab in Patients With Moderate to Severe Hidradenitis Suppurativa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: the 1-year SOLACE study
J Eur Acad Dermatol Venereol 2021 Aug 11;[EPub Ahead of Print], W Gulliver, A Alavi, MC Wiseman, MJ Gooderham, J Rao, MS Alam, KA Papp, O Desjardins, C JeanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.